Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L23a pseudogene 97 (RPL23AP97)
- Target
- RPL23AP97
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribosomal protein L23a pseudogene 97 (RPL23AP97) is a processed pseudogene located on human chromosome 13[1][6]. Pseudogenes are sequences that resemble known genes but do not code for functional proteins, often resulting from genomic duplication or retrotransposition events[4][1]. RPL23AP97 shares high sequence similarity with the functional ribosomal protein L23a (RPL23A) gene, which is a component of the 60S ribosomal subunit, but RPL23AP97 lacks protein-coding capability. While some ribosomal protein pseudogenes are transcribed and may play roles in gene regulation, no specific function or clinical association has been attributed to RPL23AP97[2][1][4]. There are no known drugs or therapeutic interventions targeting this pseudogene.
- Other names
- RPL23AP97
02
Biological functions
Other (No established protein-coding function. As a processed pseudogene, it does not contribute to protein synthesis. Some ribosomal protein pseudogenes have been reported to regulate gene expression or act as non-coding RNAs, but no specific function is attributed to RPL23AP97)
03
Disease associations
Other (No specific disease association reported for RPL23AP97. Some other ribosomal pseudogene family members have been implicated in cancer biology and gene regulation, but RPL23AP97 itself lacks such evidence)
Beyond the preview
Go deeper on Ribosomal protein L23a pseudogene 97 (RPL23AP97).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L23a pseudogene 97 (RPL23AP97).